Biomarin Pharmaceutical (BMRN) Equity Income (2009 - 2021)
Biomarin Pharmaceutical (BMRN) reported Equity Income of $177,000 for Q3 2021, compared with -$921,000 a year earlier.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) Equity Income (2009 - 2021) Analysis & Trends
Over the twelve months ended Sep 30, 2021, Biomarin Pharmaceutical's Equity Income came in at -$278,000; for FY2020, it came in at -$6,000.
- By year, Equity Income came in at -$587,000 in FY2019, -$553,000 in FY2018, -$1.29 million in FY2017 and -$538,000 in FY2016.
- Five-year quarterly Equity Income spans a low of -$1.35 million in Q1 2021 and a high of $1.07 million in Q4 2020.
- Per Business Quant data, the three quarters before Q3 2021 came in at -$175,000 (Q2 2021), -$1.35 million (Q1 2021) and $1.07 million (Q4 2020).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -10.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Biomarin Pharmaceutical | 11.61 Bn | 5.48 Bn | 786.91 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | 177,000.00 |
| Jun 30, 2021 | -175,000.00 |
| Mar 31, 2021 | -1.35 Mn |
| Dec 31, 2020 | 1.07 Mn |
| Sep 30, 2020 | -921,000.00 |
| Jun 30, 2020 | -79,000.00 |
| Mar 31, 2020 | -77,000.00 |
| Dec 31, 2019 | 193,000.00 |
| Sep 30, 2019 | -551,000.00 |
| Jun 30, 2019 | -44,000.00 |
| Mar 31, 2019 | -185,000.00 |
| Dec 31, 2018 | -46,000.00 |
| Sep 30, 2018 | -468,000.00 |
| Jun 30, 2018 | -107,000.00 |
| Mar 31, 2018 | 68,000.00 |
| Dec 31, 2017 | -295,000.00 |
| Sep 30, 2017 | -253,000.00 |
| Jun 30, 2017 | -220,000.00 |
| Mar 31, 2017 | -523,000.00 |
| Dec 31, 2016 | -164,000.00 |
API Access
Biomarin Pharmaceutical Equity Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=equity-income&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "equity-income", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=equity-income&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();